Menu
GeneBe

19-4090603-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_030662.4(MAP2K2):c.1198G>T(p.Val400Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V400M) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)

Consequence

MAP2K2
NM_030662.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.587
Variant links:
Genes affected
MAP2K2 (HGNC:6842): (mitogen-activated protein kinase kinase 2) The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.108239084).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MAP2K2NM_030662.4 linkuse as main transcriptc.1198G>T p.Val400Leu missense_variant 11/11 ENST00000262948.10
MAP2K2XM_006722799.3 linkuse as main transcriptc.919G>T p.Val307Leu missense_variant 9/9
MAP2K2XM_047439100.1 linkuse as main transcriptc.628G>T p.Val210Leu missense_variant 9/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MAP2K2ENST00000262948.10 linkuse as main transcriptc.1198G>T p.Val400Leu missense_variant 11/111 NM_030662.4 P1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 18, 2023The c.1198G>T (p.V400L) alteration is located in exon 11 (coding exon 11) of the MAP2K2 gene. This alteration results from a G to T substitution at nucleotide position 1198, causing the valine (V) at amino acid position 400 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.071
T
BayesDel_noAF
Benign
-0.34
Cadd
Benign
17
Dann
Uncertain
0.98
DEOGEN2
Benign
0.28
T;T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.49
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.75
T;T
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.11
T;T
MetaSVM
Benign
-0.44
T
MutationAssessor
Benign
0.90
L;.
MutationTaster
Benign
0.85
D;D
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.76
N;N
REVEL
Benign
0.12
Sift
Benign
0.11
T;T
Sift4G
Benign
0.16
T;T
Polyphen
0.17
B;.
Vest4
0.076
MutPred
0.20
Loss of methylation at R397 (P = 0.1463);.;
MVP
0.58
MPC
0.43
ClinPred
0.36
T
GERP RS
2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.037
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr19-4090601; API